CSIMarket
 
Thorne Healthtech Inc   (THRN)
Other Ticker:  
 
 
Price: $10.1900 $-0.01 -0.098%
Day's High: $10.2 Week Perf: 0.1 %
Day's Low: $ 10.19 30 Day Perf: 0.49 %
Volume (M): 85 52 Wk High: $ 10.20
Volume (M$): $ 862 52 Wk Avg: $6.31
Open: $10.19 52 Wk Low: $4.25



 Market Capitalization (Millions $) 549
 Shares Outstanding (Millions) 54
 Employees -
 Revenues (TTM) (Millions $) 256
 Net Income (TTM) (Millions $) 20
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 39

Thorne Healthtech Inc
Thorne Healthtech Inc. is a privately-owned company that specializes in creating and developing nutritional supplements for individuals, as well as health practitioners. The company has been around for over 30 years and started as a small, family-run business in Idaho, USA. Now, Thorne Healthtech has grown into a global brand with customers in more than 60 countries worldwide.

Thorne Healthtech's mission is to help individuals achieve optimal health and wellness through science-backed nutritional supplements. The company has a team of scientists, nutritionists, and healthcare professionals who develop supplements using high-quality ingredients that are backed by research and meet rigorous standards for purity and efficacy.

One of the unique aspects of Thorne Healthtech is its commitment to testing and transparency. The company has its own in-house laboratory, which allows for rigorous testing of its products at various stages of production. All Thorne Healthtech products are also third-party tested for quality and purity, and the results are available for customers to view on the company's website.

Thorne Healthtech offers a wide variety of supplements, from multivitamins and minerals to probiotics, sports performance supplements, and even products specifically designed for children. Some of its most popular products include:

- Meriva-SF, a curcumin supplement for joint and muscle support
- Basic Nutrients 2/Day, a comprehensive multivitamin and mineral supplement
- Multi-Vitamin Elite, a high-potency multivitamin for athletes and active individuals
- MediClear, a nutritional supplement designed to support liver detoxification
- Floramend Prime Probiotic, a probiotic supplement for digestive and immune health

In addition to its individual products, Thorne Healthtech also offers programs for health practitioners, including education and training on how to use supplements in patient care. The company also partners with sports teams and organizations to provide supplements for athletes.

Overall, Thorne Healthtech is a well-respected and trusted brand in the nutritional supplement industry, known for its commitment to science, quality, and transparency.


   Company Address: 152 W. 57th Street New York 10019 NY
   Company Phone Number: 251-6321   Stock Exchange / Ticker: NASDAQ THRN
   THRN is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Thorne Healthtech Inc

Thorne Healthtech Inc Sees Revenue Deterioration in Q2 of 2023, Despite Strong Performance



In its recently released financial results for the period from April to June 30, 2023, Thorne Healthtech Inc demonstrated a positive trend in revenue growth and significant improvement in profitability. Despite a decrease in net profit per share compared to the previous year, the company's revenue saw a notable increase of 29.69%. These results indicate that Thorne Healthtech Inc has outperformed its industry peers in terms of revenue growth.
Financial Performance Overview:
Thorne Healthtech Inc reported a per-share net profit of $0.08, which marks a decline from the $0.11 earned in the same period last year. Meanwhile, the company's revenue rose by 29.69% during this time. Comparing these figures to the prior period, Thorne Healthtech Inc showed a profit turnaround from a net loss per share of $-0.01, accompanied by an 11.461% revenue increase from $65.24 million.

Thorne Healthtech Inc

Thorne Healthtech Inc Faces Profitability Setback Despite Impressive Revenue Growth

Thorne Healthtech Inc's recent financial results show that the company has had a mixed performance in the fiscal year ending March 31, 2023. While the revenue grew by 19.334% year-on-year to reach $65.24 million, the company slipped into a loss of $-0.01 per share, compared to earnings of $0.09 per share last year. Additionally, earnings per share fell from $0.23 to $-0.01. The company also reported a net loss of $-0.531 million, compared to earnings of $4.711 million in the same reporting period the previous year.
The company attributes the decline in earnings per share to the increased costs of operating the business and the expansion into new product lines. The revenue growth was driven by the company's strong performance in the nutritional supplement market, as well as the sale of products through online platforms.






 

Thorne Healthtech Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com